Table 2.
Patients’ characteristics of the groups with and without recurrence.
| Recurrence (n = 24) |
No Recurrence (n = 19) |
P | |
|---|---|---|---|
| Age, years | 65 (58, 70) | 64 (57, 73) | * n.s. |
| Sex, male, n (%) | 18 (75) | 15 (89) | + n.s. |
| Etiology, HCV/HBV/Alcohol, n (%) | 17 (71)/1 (4)/3 (3) | 8 (38)/2 (11)/4 (21) | + n.s. |
| HCC present, n (%) | 9 (38) | 7 (37) | + n.s. |
| Treatment history of splenectomy or PSE, n (%) | 5 (21) | 2 (11) | + n.s. |
| Treatment history of varices, n (%) | 12 (46) | 8 (47) | + n.s. |
| Including MPV, n (%) | 21 (88) | 14 (74) | + n.s. |
| Child–Pugh score | 8 (6–11) | 8 (7–9) | * n.s. |
| ALBI score | −1.7 (−1.9–−1.4) | −1.8 (−2.1–−1.5) | * n.s. |
| FIB-4 index | 6.7 (5.1–10.1) | 8.0 (4.0–9.7) | * n.s. |
| Platelet (×104/μL) | 7.8 (5.2–11.7) | 6.8 (5.5–11.0) | ** n.s. |
| PT activity (%) | 67 (57–74) | 62 (56–72) | * n.s. |
| Albumin (mg/dL) | 3.1 (2.8–3.3) | 3.1 (2.8–3.4) | * n.s. |
| T-Bil (mg/dL) | 1.6 (0.9–2.5) | 1.1 (0.9–1.5) | ** n.s. |
| AT-III (%) | 62 (47–72) | 55 (47–69) | * n.s. |
| FDP (μg/mL) | 9.0 (5.9–32.3) | 8.4 (4.4–17.8) | ** n.s. |
| DD (μg/mL) | 4.6 (2.8–11.7) | 3.7 (1.7–7.6) | ** n.s. |
| Pretreatment PVT (mL) | 3.8 (2.4–7.7) | 2.0 (1.2–5.4) | ** 0.019 |
Median (IQR); * Student‘s t-test; ** Mann–Whitney U test; + χ2 test or Fisher exact test.